EconPapers    
Economics at your fingertips  
 

Functional improvement of dystrophic muscle by myostatin blockade

Sasha Bogdanovich, Thomas O. B. Krag, Elisabeth R. Barton, Linda D. Morris, Lisa-Anne Whittemore, Rexford S. Ahima and Tejvir S. Khurana ()
Additional contact information
Sasha Bogdanovich: University of Pennsylvania School of Medicine
Thomas O. B. Krag: University of Pennsylvania School of Medicine
Elisabeth R. Barton: University of Pennsylvania School of Medicine
Linda D. Morris: University of Pennsylvania School of Medicine
Lisa-Anne Whittemore: Musculoskeletal Sciences Department, Wyeth Research
Rexford S. Ahima: University of Pennsylvania School of Medicine
Tejvir S. Khurana: University of Pennsylvania School of Medicine

Nature, 2002, vol. 420, issue 6914, 418-421

Abstract: Abstract Mice1,2 and cattle3 with mutations in the myostatin (GDF8) gene show a marked increase in body weight and muscle mass, indicating that this new member of the TGF-β superfamily is a negative regulator of skeletal muscle growth. Inhibition of the myostatin gene product is predicted to increase muscle mass and improve the disease phenotype in a variety of primary and secondary myopathies. We tested the ability of inhibition of myostatin in vivo to ameliorate the dystrophic phenotype in the mdx mouse model of Duchenne muscular dystrophy (DMD)4,5,6,7,8. Blockade of endogenous myostatin by using intraperitoneal injections of blocking antibodies for three months resulted in an increase in body weight, muscle mass, muscle size and absolute muscle strength in mdx mouse muscle along with a significant decrease in muscle degeneration and concentrations of serum creatine kinase. The functional improvement of dystrophic muscle by myostatin blockade provides a novel, pharmacological strategy for treatment of diseases associated with muscle wasting such as DMD, and circumvents the major problems associated with conventional gene therapy in these disorders.

Date: 2002
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature01154 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:420:y:2002:i:6914:d:10.1038_nature01154

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature01154

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:nature:v:420:y:2002:i:6914:d:10.1038_nature01154